NCT00406432View on ClinicalTrials.gov

A Repeat Dose Pharmacokinetic Study Of Paroxetine CR Tablet In Healthy Chinese Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

May 9, 2006

Primary Completion Date

June 2, 2006

Study Completion Date

June 2, 2006

Conditions

Depressive Disorder

Interventions

DRUG

Paroxetine Controlled Release Tablet

Eligible subjects will receive paroxetine controlled release tablet with dose of 25 milligrams.

Trial Locations (1)

100730

GSK Investigational Site, Beijing

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY